Factors affecting sentinel lymph node detection failure in breast cancer patients using intradermal injection of the tracer

Revista Espanola de Medicina Nuclear

Volumn 29, Issue 2, 2010, Pages 73-77

  Abdollahi, A ^a   Jangjoo, A ^b   Dabbagh Kakhki, V R ^c   Rasoul Zakavi, S ^c   Memar, B ^b   Naser Forghani, M ^a   Mehrabibahar, M ^b   Sadeghi, R ^c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Intradermal injection; Lymphoscintigraphy; Peri areolar injection; Sentinel node detection failure

Indexed keywords

ANTIMONY TECHNETIUM SULFIDE TC 99M;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CONTROLLED STUDY; HUMAN; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

ADULT; ANTIMONY; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COLORING AGENTS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM COMPOUNDS;

EID: 77349110016     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/j.remn.2009.10.001     Document Type: Article

References (37)

1. Vidal-Sicart S., and Rioja Martin M.E. Scintigraphic and intraoperative detection of the sentinel lymph node in breast cancer. Rev Esp Med Nucl 28 (2009) 41-43
2. Rubi S., Vidal-Sicar S., Ortega M., Domenech B., Lafuente S., Corral J.M., et al. Localization of sentinel node in squamous cell carcinoma of the penis. Initial experience. Rev Esp Med Nucl 27 (2008) 3-7
3. Mansel R.E., Fallowfield L., Kissin M., Goyal A., Newcombe R.G., Dixon J.M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98 (2006) 599-609
4. Soni N.K., and Spillane A.J. Experience of sentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node. ANZ J Surg 75 (2005) 292-299
5. Fleissig A., Fallowfield L.J., Langridge C.I., Johnson L., Newcombe R.G., Dixon J.M., et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95 (2006) 279-293
6. Syme D.B., Collins J.P., and Mann G.B. Comparison of blue dye and isotope with blue dye alone in breast sentinel node biopsy. ANZ J Surg 75 (2005) 817-821
7. Krausz Y., Ikeda D.M., Jadvar H., Langleben D., Birdwell R., and Strauss H.W. Non-visualization of sentinel lymph node in patients with breast cancer. Nucl Med Commun 22 (2001) 25-32
8. Straalman K., Kristoffersen U.S., Galatius H., and Lanng C. Factors influencing sentinel lymph node identification failure in breast cancer surgery. Breast 17 (2008) 167-171
9. Soran A., Falk J., Bonaventura M., Keenan D., Ahrendt G., and Johnson R. Does failure to visualize a sentinel node on preoperative lymphoscintigraphy predict a greater likelihood of axillary lymph node positivity?. J Am Coll Surg 205 (2007) 66-71
10. Pritsivelis C., Garcia Mendonca C.A., Pinheiro Pessoa M.C., Coelho-Oliveira A., Gutfilen B., and Barbosa Da Fonseca L.M. Failure predictors of the sentinel lymph node in patients with breast cancer using Tc-99m sulfur colloid and periareolar injection. Q J Nucl Med Mol Imaging 51 (2007) 189-193
11. Chagpar A.B., Martin R.C., Scoggins C.R., Carlson D.J., Laidley A.L., El-Eid S.E., et al. Factors predicting failure to identify a sentinel lymph node in breast cancer. Surgery 138 (2005) 56-63
12. Sener S.F., Winchester D.J., Brinkmann E., Winchester D.P., Alwawi E., Nickolov A., et al. Failure of sentinel lymph node mapping in patients with breast cancer. J Am Coll Surg 198 (2004) 732-736
13. Wu C.T., Morita E.T., Treseler P.A., Esserman L.J., Hwang E.S., Kuerer H.M., et al. Failure to harvest sentinel lymph nodes identified by preoperative lymphoscintigraphy in breast cancer patients. Breast J 9 (2003) 86-90
14. Cox C.E., Dupont E., Whitehead G.F., Ebert M.D., Nguyen K., Peltz E.S., et al. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J 8 (2002) 88-91
15. Chakera A.H., Friis E., Hesse U., Al-Suliman N., Zerahn B., and Hesse B. Factors of importance for scintigraphic non-visualisation of sentinel nodes in breast cancer. Eur J Nucl Med Mol Imaging 32 (2005) 286-293
16. Pelosi E., Ala A., Bello M., Douroukas A., Migliaretti G., Berardengo E., et al. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer. Eur J Nucl Med Mol Imaging 32 (2005) 937-942
17. Bembenek A., Fischer J., Albrecht H., Kemnitz E., Gretschel S., Schneider U., et al. Impact of patient- and disease-specific factors on SLNB in breast cancer patients. Are current guidelines justified?. World J Surg 31 (2007) 267-275
18. Tafra L., Lannin D.R., Swanson M.S., Van Eyk J.J., Verbanac K.M., Chua A.N., et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 233 (2001) 51-59
19. Rousseau C., Classe J.M., Campion L., Curtet C., Dravet F., Pioud R., et al. The impact of nonvisualization of sentinel nodes on lymphoscintigraphy in breast cancer. Ann Surg Oncol 12 (2005) 533-538
20. Pichler-Gebhard B., Konstantiniuk P., Tausch C., Joerg L., Haid A., Schrenk P., et al. Factors affecting identification rate and positivity of the sentinel node in breast cancer in 1567 patients, using blue dye and 99mTc-labelled colloid, based on a multicentre database project in Austria. European Surgery-Acta Chirurgica Austriaca 34 (2002) 272-276
21. Shabani G.A., Hamzeh H., and Najafi R. Production of 99mTc-Antimony Sulfide Colloid for lymphoscintigraphy. Iran J Nucl Med 19 (2003) 57-65
22. Buscombe J., Paganelli G., Burak Z.E., Waddington W., Maublant J., Prats E., et al. Sentinel node in breast cancer procedural guidelines. Eur J Nucl Med Mol Imaging 34 (2007) 2154-2159
23. Sadeghi R., Forghani M.N., Memar B., Rajabi Mashhadi M.T., Dabbagh Kakhki V.R., Abdollahi A., et al. How long the lymphoscintigraphy imaging should be continued for sentinel lymph node mapping?. Ann Nucl Med 23 (2009) 507-510
24. Sadeghi R., Forghani M.N., Memar B., Abdollahi A., Zakavi S.R., Mashhadi M.T., et al. Comparison of pre-operative lymphoscintigraphy with inter-operative gamma probe and dye technique regarding the number of detected sentinel lymph nodes. Hell J Nucl Med 12 (2009) 30-32
25. Tanis P.J., Valdes Olmos R.A., Muller S.H., and Nieweg O.E. Lymphatic mapping in patients with breast carcinoma: reproducibility of lymphoscintigraphic results. Radiology 228 (2003) 546-551
26. Birdwell R.L., Smith K.L., Betts B.J., Ikeda D.M., Strauss H.W., and Jeffrey S.S. Breast cancer: variables affecting sentinel lymph node visualization at preoperative lymphoscintigraphy. Radiology 220 (2001) 47-53
27. Vargas H.I., Vargas M.P., Venegas R., and Mamounas E.P. Lymphatic tumor burden negatively impacts the ability to detect the sentinel lymph node in breast cancer. Breast Diseases 15 (2004) 178-179
28. Aarsvold J.N., and Alazraki N.P. Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med 35 (2005) 116-128
29. Classe J.M., Curtet C., Campion L., Rousseau C., Fiche M., Sagan C., et al. Learning curve for the detection of axillary sentinel lymph node in breast cancer. Eur J Surg Oncol 29 (2003) 426-433
30. Lamonica D., Edge S.B., Hurd T., Proulx G., and Stomper P.C. Mammographic and clinical predictors of drainage patterns in breast lymphoscintigrams obtained during sentinel node procedures. Clin Nucl Med 28 (2003) 558-564
31. Krag D., Weaver D., Ashikaga T., Moffat F., Klimberg V.S., Shriver C., et al. The sentinel node in breast cancer--a multicenter validation study. N Engl J Med 339 (1998) 941-946
32. McMasters K.M., Wong S.L., Martin 2nd R.C., Chao C., Tuttle T.M., Noyes R.D., et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 233 (2001) 676-687
33. Jinno H., Ikeda T., Asaga S., Muto T., Kitagawa Y., Fujii H., et al. Increasing age does not affect efficacy of sentinel lymph node biopsy using smaller-sized technetium-99m tin colloids for breast cancer patients. Am J Surg 190 (2005) 51-54
34. Ruano R., Ramos M., Garcia-Talavera J.R., Garcia Macias M.C., Martin de Arriba A., Gonzalez-Orus J.M., et al. Sentinel node biopsy in T2 breast cancers larger than 3 cm and clinically negative axilla compared with the T1-T2 <3 cm standard indication. Rev Esp Med Nucl 27 (2008) 176-182
35. Koizumi M., Nomura E., Yamada Y., Takiguchi T., Tanaka K., Yoshimoto M., et al. Sentinel node detection using 99mTc-rhenium sulphide colloid in breast cancer patients: evaluation of 1 day and 2 day protocols, and a dose-finding study. Nucl Med Commun 24 (2003) 663-670
36. Ohtake E., Asaga T., and Inaba M. Sentinel lymphoscintigraphy in patients with breast cancer undergoing excisional biopsy. Ann Nucl Med 19 (2005) 671-675
37. Haigh P.I., Hansen N.M., Qi K., and Giuliano A.E. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 7 (2000) 21-27